Cardiogenic shock remains the leading cause of death in patients admitted for acute myocardial infarction [ ]. In the past two decades, the mortality has remained unchanged at around 40–50%. Apart from early revascularisation, there is no evidence that the current treatment strategies are effective in improving survival [ ].
展开▼